Growth Metrics

Merck (MRK) Total Current Liabilities (2016 - 2026)

Merck has reported Total Current Liabilities over the past 18 years, most recently at $26.9 billion for Q1 2026.

  • Quarterly Total Current Liabilities rose 7.04% to $26.9 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $26.9 billion through Mar 2026, up 7.04% year-over-year, with the annual reading at $28.3 billion for FY2025, 0.33% changed from the prior year.
  • Total Current Liabilities was $26.9 billion for Q1 2026 at Merck, down from $28.3 billion in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $29.6 billion in Q3 2024 and troughed at $22.3 billion in Q1 2022.
  • The 5-year median for Total Current Liabilities is $25.2 billion (2025), against an average of $25.4 billion.
  • Year-over-year, Total Current Liabilities fell 15.34% in 2022 and then grew 28.11% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $24.2 billion in 2022, then increased by 6.0% to $25.7 billion in 2023, then rose by 10.61% to $28.4 billion in 2024, then decreased by 0.33% to $28.3 billion in 2025, then fell by 4.88% to $26.9 billion in 2026.
  • Per Business Quant, the three most recent readings for MRK's Total Current Liabilities are $26.9 billion (Q1 2026), $28.3 billion (Q4 2025), and $28.6 billion (Q3 2025).